Activation of sPLA2‐IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL‐1β
Open Access
- 28 June 2006
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 20 (10) , 1727-1729
Abstract
Lipid mediators such as prostaglandin E2 (PGE2) play a central role during atherogenesis as a consequence of inflammation. PGE2 is produced from phospholipids by a cascade of enzymatic reactions involving phospholipase A2 (PLA2), cyclooxygenase (COX), and prostaglandin E synthase (PGES). It is released by several cell types, including vascular smooth muscle cells (VSMCs). Recent work has shown that the secretory PLA2‐IIA (sPLA2‐IIA), the most abundant isoform of secreted PLA2 in VSMCs, acts as a potent cytokine and activates VSMCs through a positive feedback loop. High mobility group protein 1 (HMGB1), also known as amphoterin, is a ubiquitous protein that plays various roles in the nucleus. HMGB1 is released by necrotic cells and by immune cells in response to various inflammatory mediators and acts as a potent proinflammatory cytokine. The present study investigates the role of HMGB1 in the activation of sPLA2‐IIA expression and PGE2 production in VSMCs. Recombinant HMGB1 slightly activated the sPLA2‐IIA, COX‐2, and mPGES‐1 genes but dramatically stimulated these genes in VSMCs that had been incubated with the proinflammatory cytokine IL‐1β for 24 h. This effect was accompanied by significantly increased PGE2 release. Induction of the three known receptors of HMGB1, namely RAGE, TLR‐2, and TLR‐4, by IL‐1β suggests that proinflammatory cytokines sensitize VSMCs to HMGB1. This provides new insights into the role of HMGB1 in VSMCs, suggesting it may be essential for the progression of atherosclerosis.—Jaulmes, A., Thierry, S., Janvier, B., Raymondjean, M., Maréchal, V. Activation of sPLA2‐IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by interleukin (IL)‐1β. FASEB J. 20, E1086–E1093 (2006)Keywords
Funding Information
- Centre National de la Recherche Scientifique
- Université Pierre et Marie Curie
- Ministère de l'Enseignement supérieur et de la Recherche
This publication has 45 references indexed in Scilit:
- Autocrine and Paracrine Transcriptional Regulation of Type IIA Secretory Phospholipase A2 Gene in Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategiesNature Medicine, 2002
- Biological effects of group IIA secreted phosholipase A2FEBS Letters, 2002
- Up-regulation of Prostaglandin E2 Synthesis by Interleukin-1β in Human Orbital Fibroblasts Involves Coordinate Induction of Prostaglandin-Endoperoxide H Synthase-2 and Glutathione-dependent Prostaglandin E2 Synthase ExpressionJournal of Biological Chemistry, 2002
- Why there are two cyclooxygenase isozymesJournal of Clinical Investigation, 2001
- Transcriptional regulation of inflammatory secreted phospholipases A2Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2Journal of Biological Chemistry, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Functional Coupling Between Various Phospholipase A2s and Cyclooxygenases in Immediate and Delayed Prostanoid Biosynthetic PathwaysJournal of Biological Chemistry, 1999
- Localization of Nonpancreatic Secretory Phospholipase A 2 in Normal and Atherosclerotic ArteriesArteriosclerosis, Thrombosis, and Vascular Biology, 1997